Select Page

Absence of Social Support, Stressful Environments Linked to Adverse Outcomes for Psychedelics Users

Media Partners, Psychedelic News Wire

This post is presented by our media partner Psychedelic News Wire
View the original article here.

Scientists from the Imperial College London’s Center for Psychedelic Research have published a study indicating that psychedelics are linked to adverse outcomes when users  are in stressful environments and have limited social support. Published in the “Scientific Reports” journal, the study delved into the potential negative psychological effects associated with psychedelic drug use.

The study found that in the absence of social support, psychedelic users are at risk of experiencing psychological issues such as panic and persistent anxiety, especially if they are in particularly stressful environments.

With the recent resurgence in psychedelic research contributing to significant hype around the mental-health benefits of hallucinogens such as psilocybin (magic mushrooms), MDMA and LSD, researchers thought to counter by focusing wholly on the negative aspects of psychedelic consumption. Several studies have found that psychedelics can be quite effective at alleviating the symptoms of typically hard-to-treat mental disorders, especially when it is paired with traditional talk therapy. While the psychedelic itself is critical to the treatment, the therapy part of psychedelic-assisted therapy is essential to creating the best treatment outcomes.

But while all of the studies associating psychedelics with mental-health benefits take place in tightly controlled environments, most psychedelic use happens outside of research settings. Consequently, researchers worried that the growing body of psychedelic research may not be fully representative of how psychedelics can affect individuals outside of controlled research or medical environments.

Study author Rehecka Bremle says she and her team were interested in finding the potential risk factors that contribute to negative psychological responses during or after psychedelic consumption. The research team ran a two-phase study that first involved an online survey composed of the Challenging Experience Questionnaire (CEQ) to measure negative experience intensity as well as other questionnaires.  A second smaller group of 15 from the pool of 84 participants was then chosen for in-depth interviews by experts in the mental-health field.

Participants reported going through frightening or negative experiences (bad trips) while under the influence of classic psychedelics such as LSD. Anxiety and panic were the most reported symptoms. Researchers also found that some participants experienced derealization and flashbacks of their negative experiences.

The research team notes that factors such as drug purity and dosage, frequency of use, polysubstance use and drug-quality concerns may also contribute to negative outcomes. Furthermore, they found that unsafe or stressful environments as well as limited social support during and after the psychedelic experience contributed to negative outcomes.

A lot is still being discovered about how to leverage the benefits of psychedelics, and the studies that are being conducted by startups such as Seelos Therapeutics Inc. (NASDAQ: SEEL) could reveal additional nuances pertinent to tapping the medicinal attributes of these hallucinogens.

About PsychedelicNewsWire

PsychedelicNewsWire (“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

PsychedelicNewsWire
San Francisco, CA
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicNewsWire.com

PsychedelicNewsWire is powered by IBN

This post was originally published by our media partner here.